THL Partners, Thursday announced an agreement to Headlands Research, a multinational network of clinical trial sites, from funds managed by KKR & Co. Inc. (KKR).
The deal is expected to boost Headlands' continued expansion, enhance its technology and centralized infrastructure, and further strengthen its ability to deliver high-quality, diverse clinical trial data for pharmaceutical and biotech sponsors.
THL will finance the deal, expected to close this year, with its flagship Fund IX.
Currently, KKR is trading at $146.40, down 0.81 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.